DNAprint Genomics (DNAG)

[dgplexus]

They aren't doing regular SEC filings, as a prudent cost-cutting measure. I'd rather they cut costs and continue operating, than to not cut costs, and end the whole thing as a result. They have income streams, and in a situation like this, that can easily make the difference (combined with cost cutting.)

I do not accept the idea that recent prices are reflective of value. We have seen _extremely_ blatant price manipulation (to the downside) combined with nonstop, industrial scale bashing. Price manipulation alone corrupts price discovery, and the bashing makes it even worse.

I consider DNAG to be the world's most undervalued stock.